Curriculum · Screening (National/International)
Phenylketonuria screening
What it is
Phenylketonuria (PKU) is the most common IEM of amino acid metabolism. Inheritance is autosomal recessive and the defective enzyme is phenylalanine hydroxylase (PAH), so the phenylalanine level rises and phenylalanine, phenylpyruvate and phenylacetate accumulate.
How it presents
Symptoms are often absent at birth, so the diagnosis is made by screening rather than by the picture. Where features do appear they are:
- Intellectual disability
- Seizures
- Fair skin and hair, and hair loss
- Eczema
- A musty urine odor, which comes from phenylacetate
Brain damage follows the rise in phenylalanine.
How it is diagnosed
PKU screening is a heel-prick screening in newborns in the neonatal period, and it sits alongside the wider newborn metabolic disorders screen, a heel-prick blood test in all newborns shortly after birth. The screening test itself is the Guthrie test or tandem mass spectrometry for phenylalanine. High phenylalanine levels are then confirmed by PAH gene mutation.